Barclays’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $272K | Sell |
5,513
-96,432
| -95% | -$4.9M | ﹤0.01% | 3539 |
|
|
2026
Q1 | $5.44M | Buy |
101,945
+100,793
| +8,749% | +$5.92M | ﹤0.01% | 1764 |
|
|
2025
Q4 | $71.6K | Sell |
1,152
-2,058
| -64% | -$127K | ﹤0.01% | 4667 |
|
|
2025
Q3 | $193K | Buy |
3,210
+196
| +7% | +$12K | ﹤0.01% | 4337 |
|
|
2025
Q2 | $189K | Buy |
3,014
+1,412
| +88% | +$84.9K | ﹤0.01% | 4320 |
|
|
2025
Q1 | $96.4K | Sell |
1,602
-12,694
| -89% | -$788K | ﹤0.01% | 4427 |
|
|
2024
Q4 | $834K | Buy |
14,296
+4,875
| +52% | +$290K | ﹤0.01% | 3499 |
|
|
2024
Q3 | $558K | Sell |
9,421
-145,472
| -94% | -$8.31M | ﹤0.01% | 3702 |
|
|
2024
Q2 | $8.68M | Sell |
154,893
-197,202
| -56% | -$11M | ﹤0.01% | 1252 |
|
|
2024
Q1 | $20.6M | Buy |
352,095
+347,577
| +7,693% | +$19.6M | 0.01% | 969 |
|
|
2023
Q4 | $244K | Sell |
4,518
-16,095
| -78% | -$786K | ﹤0.01% | 4332 |
|
|
2023
Q3 | $1,000K | Buy |
20,613
+12,844
| +165% | +$683K | ﹤0.01% | 2337 |
|
|
2023
Q2 | $439K | Buy |
7,769
+3,029
| +64% | +$167K | ﹤0.01% | 2837 |
|
|
2023
Q1 | $256K | Sell |
4,740
-1,765
| -27% | -$94K | ﹤0.01% | 3660 |
|
|
2022
Q4 | $342K | Sell |
6,505
-990
| -13% | -$50.2K | ﹤0.01% | 3541 |
|
|
2022
Q3 | $354K | Sell |
7,495
-2,935
| -28% | -$152K | ﹤0.01% | 2882 |
|
|
2022
Q2 | $526K | Sell |
10,430
-16,500
| -61% | -$899K | ﹤0.01% | 2811 |
|
|
2022
Q1 | $1.64M | Buy |
26,930
+2,710
| +11% | +$162K | ﹤0.01% | 2022 |
|
|
2021
Q4 | $1.59M | Hold |
24,220
| – | – | ﹤0.01% | 2514 |
|
|
2021
Q3 | $1.52M | Sell |
24,220
-1,004,084
| -98% | -$64.1M | ﹤0.01% | 2525 |
|
|
2021
Q2 | $61.9M | Buy |
1,028,304
+128,304
| +14% | +$7.42M | 0.03% | 437 |
|
|
2021
Q1 | $49.6M | Hold |
900,000
| – | – | 0.03% | 448 |
|
|
2020
Q4 | $49.1M | Hold |
900,000
| – | – | 0.03% | 461 |
|
|
2020
Q3 | $44.9M | Sell |
900,000
-2,352
| -0.3% | -$114K | 0.03% | 430 |
|
|
2020
Q2 | $39.8M | Buy |
+902,352
| New | +$38.6M | 0.03% | 391 |
|
|
2020
Q1 | – | Sell |
-900,000
| Closed | -$39.6M | – | 6285 |
|
|
2019
Q4 | $39.6M | Hold |
900,000
| – | – | 0.02% | 602 |
|
|
2019
Q3 | $37.1M | Buy |
+900,000
| New | +$36.8M | 0.02% | 572 |
|
|
2018
Q4 | – | Sell |
-6,000
| Closed | -$227K | – | 7107 |
|
|
2018
Q3 | $227K | Buy |
+6,000
| New | +$213K | ﹤0.01% | 4901 |
|
|
2018
Q2 | – | Sell |
-15,300
| Closed | -$472K | – | 7092 |
|
|
2018
Q1 | $472K | Buy |
15,300
+14,700
| +2,450% | +$453K | ﹤0.01% | 4029 |
|
|
2017
Q4 | $17K | Hold |
600
| – | – | ﹤0.01% | 6351 |
|
|
2017
Q3 | $17K | Hold |
600
| – | – | ﹤0.01% | 5865 |
|
|
2017
Q2 | $17K | Sell |
600
-1,650
| -73% | -$43.7K | ﹤0.01% | 5867 |
|
|
2017
Q1 | $56K | Buy |
2,250
+1,380
| +159% | +$33.5K | ﹤0.01% | 5274 |
|
|
2016
Q4 | $19K | Buy |
+870
| New | +$19.8K | ﹤0.01% | 5648 |
|
|
2013
Q3 | – | Sell |
-117,000
| Closed | -$1.53M | – | 7502 |
|
|
2013
Q2 | $1.53M | Buy |
+117,000
| New | +$1.52M | ﹤0.01% | 2835 |
|
Other funds holding IHI
AAS
Barclays's IHI Position: Q2 2026 in Review
Barclays reduced its iShares US Medical Devices ETF (IHI) stake by 95% in Q2 2026, selling an estimated $4.9M and leaving 5,513 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #3539.
Barclays first reported a position in IHI in Q2 2013 and has held it in 35 quarters since. The position peaked at $61.9M in Q2 2021. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.
- Barclays held 5,513 shares of iShares US Medical Devices ETF worth $272K as of Q2 2026.
- Barclays sold 96,432 iShares US Medical Devices ETF shares in Q2 2026, an estimated $4.9M.
- iShares US Medical Devices ETF made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3539 holding.
- Barclays first reported a position in iShares US Medical Devices ETF in Q2 2013 and has held it in 35 quarters since.
- Barclays's iShares US Medical Devices ETF position peaked at $61.9M in Q2 2021.
- 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.